mRNA Vaccine and Therapeutics Landscape
Guide to mRNA platforms in development — cancer vaccines, rare disease therapies, and autoimmune treatments.
Key Highlights
- ✓ Cancer vaccine pipeline analysis
- ✓ Self-amplifying mRNA technology
- ✓ LNP delivery innovations
- ✓ Rare disease mRNA therapies
- ✓ Manufacturing scale-up challenges
Overview
A detailed guide to the mRNA therapeutics landscape beyond COVID-19 vaccines. Covers cancer vaccines, rare disease therapies, autoimmune treatments, and platform technologies enabling next-generation mRNA medicines.
What's Inside
Cancer Vaccines
Personalized mRNA cancer vaccines are entering Phase 2/3 trials. We cover Moderna-Merck's mRNA-4157 for melanoma, BioNTech's individualized neoantigen vaccines, and the manufacturing logistics of patient-specific treatments.
Platform Innovations
Self-amplifying mRNA (saRNA) and trans-amplifying mRNA (taRNA) promise lower doses and longer-lasting expression. We compare modified nucleoside strategies, circular RNA, and the next generation of lipid nanoparticle formulations.
Ready to dive in?
Explore this resource and discover more across our 12 technology frontiers.